
### [MONDO:0018730](http://purl.obolibrary.org/obo/MONDO_0018730)
**Label:** rare genetic venous malformation

**Subclasses:** [MONDO:0007203](http://purl.obolibrary.org/obo/MONDO_0007203) (blue rubber bleb nevus), [MONDO:0007672](http://purl.obolibrary.org/obo/MONDO_0007672) (Glomuvenous malformation), [MONDO:0000821](http://purl.obolibrary.org/obo/MONDO_0000821) (cerebral cavernous malformation 3), [MONDO:0010842](http://purl.obolibrary.org/obo/MONDO_0010842) (multiple cutaneous and mucosal venous malformations), [MONDO:0011305](http://purl.obolibrary.org/obo/MONDO_0011305) (cerebral cavernous malformations 3), [MONDO:0007291](http://purl.obolibrary.org/obo/MONDO_0007291) (familial cerebral cavernous malformation), [MONDO:0011304](http://purl.obolibrary.org/obo/MONDO_0011304) (cerebral cavernous malformation 2), 

**Mapped go classes:** [GO:0016525](http://purl.obolibrary.org/obo/GO_0016525) (negative regulation of angiogenesis), [GO:0032092](http://purl.obolibrary.org/obo/GO_0032092) (positive regulation of protein binding), [GO:0060047](http://purl.obolibrary.org/obo/GO_0060047) (heart contraction), [GO:0048839](http://purl.obolibrary.org/obo/GO_0048839) (inner ear development), [GO:0048514](http://purl.obolibrary.org/obo/GO_0048514) (blood vessel morphogenesis), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0000139](http://purl.obolibrary.org/obo/GO_0000139) (Golgi membrane), [GO:0005874](http://purl.obolibrary.org/obo/GO_0005874) (microtubule), [GO:0045602](http://purl.obolibrary.org/obo/GO_0045602) (negative regulation of endothelial cell differentiation), [GO:0009948](http://purl.obolibrary.org/obo/GO_0009948) (anterior/posterior axis specification), [GO:0005546](http://purl.obolibrary.org/obo/GO_0005546) (phosphatidylinositol-4,5-bisphosphate binding), [GO:0003007](http://purl.obolibrary.org/obo/GO_0003007) (heart morphogenesis), [GO:0001701](http://purl.obolibrary.org/obo/GO_0001701) (in utero embryonic development), [GO:0001944](http://purl.obolibrary.org/obo/GO_0001944) (vasculature development), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0050715](http://purl.obolibrary.org/obo/GO_0050715) (positive regulation of cytokine secretion), [GO:2000352](http://purl.obolibrary.org/obo/GO_2000352) (negative regulation of endothelial cell apoptotic process), [GO:0032403](http://purl.obolibrary.org/obo/GO_0032403) (protein complex binding), [GO:2000114](http://purl.obolibrary.org/obo/GO_2000114) (regulation of establishment of cell polarity), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0048845](http://purl.obolibrary.org/obo/GO_0048845) (venous blood vessel morphogenesis), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0045454](http://purl.obolibrary.org/obo/GO_0045454) (cell redox homeostasis), [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex), [GO:0005884](http://purl.obolibrary.org/obo/GO_0005884) (actin filament), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0045216](http://purl.obolibrary.org/obo/GO_0045216) (cell-cell junction organization), [GO:0060039](http://purl.obolibrary.org/obo/GO_0060039) (pericardium development), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0031625](http://purl.obolibrary.org/obo/GO_0031625) (ubiquitin protein ligase binding), [GO:0005911](http://purl.obolibrary.org/obo/GO_0005911) (cell-cell junction), [GO:0060837](http://purl.obolibrary.org/obo/GO_0060837) (blood vessel endothelial cell differentiation), [GO:0031464](http://purl.obolibrary.org/obo/GO_0031464) (Cul4A-RING E3 ubiquitin ligase complex), [GO:0030054](http://purl.obolibrary.org/obo/GO_0030054) (cell junction), [GO:0031462](http://purl.obolibrary.org/obo/GO_0031462) (Cul2-RING ubiquitin ligase complex), [GO:0030695](http://purl.obolibrary.org/obo/GO_0030695) (GTPase regulator activity), [GO:0031463](http://purl.obolibrary.org/obo/GO_0031463) (Cul3-RING ubiquitin ligase complex), [GO:0032434](http://purl.obolibrary.org/obo/GO_0032434) (regulation of proteasomal ubiquitin-dependent protein catabolic process), [GO:0035264](http://purl.obolibrary.org/obo/GO_0035264) (multicellular organism growth), [GO:0043009](http://purl.obolibrary.org/obo/GO_0043009) (chordate embryonic development), [GO:0005171](http://purl.obolibrary.org/obo/GO_0005171) (hepatocyte growth factor receptor binding), [GO:0031461](http://purl.obolibrary.org/obo/GO_0031461) (cullin-RING ubiquitin ligase complex), [GO:0007033](http://purl.obolibrary.org/obo/GO_0007033) (vacuole organization), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0061154](http://purl.obolibrary.org/obo/GO_0061154) (endothelial tube morphogenesis), [GO:0001570](http://purl.obolibrary.org/obo/GO_0001570) (vasculogenesis), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0004713](http://purl.obolibrary.org/obo/GO_0004713) (protein tyrosine kinase activity), [GO:0001885](http://purl.obolibrary.org/obo/GO_0001885) (endothelial cell development), [GO:0001886](http://purl.obolibrary.org/obo/GO_0001886) (endothelial cell morphogenesis), [GO:0001843](http://purl.obolibrary.org/obo/GO_0001843) (neural tube closure), [GO:0005925](http://purl.obolibrary.org/obo/GO_0005925) (focal adhesion), [GO:0001568](http://purl.obolibrary.org/obo/GO_0001568) (blood vessel development), [GO:0004714](http://purl.obolibrary.org/obo/GO_0004714) (transmembrane receptor protein tyrosine kinase activity), [GO:0001525](http://purl.obolibrary.org/obo/GO_0001525) (angiogenesis), [GO:0001725](http://purl.obolibrary.org/obo/GO_0001725) (stress fiber), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0055105](http://purl.obolibrary.org/obo/GO_0055105) (ubiquitin-protein transferase inhibitor activity), [GO:0010596](http://purl.obolibrary.org/obo/GO_0010596) (negative regulation of endothelial cell migration), [GO:0042327](http://purl.obolibrary.org/obo/GO_0042327) (positive regulation of phosphorylation), [GO:0007043](http://purl.obolibrary.org/obo/GO_0007043) (cell-cell junction assembly), [GO:0007169](http://purl.obolibrary.org/obo/GO_0007169) (transmembrane receptor protein tyrosine kinase signaling pathway), [GO:0007166](http://purl.obolibrary.org/obo/GO_0007166) (cell surface receptor signaling pathway), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0040029](http://purl.obolibrary.org/obo/GO_0040029) (regulation of gene expression, epigenetic), [GO:0008017](http://purl.obolibrary.org/obo/GO_0008017) (microtubule binding), [GO:0045086](http://purl.obolibrary.org/obo/GO_0045086) (positive regulation of interleukin-2 biosynthetic process), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0005856](http://purl.obolibrary.org/obo/GO_0005856) (cytoskeleton), [GO:0072554](http://purl.obolibrary.org/obo/GO_0072554) (blood vessel lumenization), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0042130](http://purl.obolibrary.org/obo/GO_0042130) (negative regulation of T cell proliferation), [GO:0042692](http://purl.obolibrary.org/obo/GO_0042692) (muscle cell differentiation), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0072359](http://purl.obolibrary.org/obo/GO_0072359) (circulatory system development), [GO:0001937](http://purl.obolibrary.org/obo/GO_0001937) (negative regulation of endothelial cell proliferation), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), 

**Class expressions from DL-Learner:**

- Thing 53.00%
- [GO:0005925](http://purl.obolibrary.org/obo/GO_0005925) (focal adhesion) 52.27%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) 37.63%
- [GO:0030055](http://purl.obolibrary.org/obo/GO_0030055) (cell-substrate junction) and [GO:0070161](http://purl.obolibrary.org/obo/GO_0070161) (anchoring junction) 37.63%
- [GO:0005912](http://purl.obolibrary.org/obo/GO_0005912) (adherens junction) and [GO:0030055](http://purl.obolibrary.org/obo/GO_0030055) (cell-substrate junction) 37.63%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001221](http://purl.obolibrary.org/obo/GO_2001221) (obsolete positive regulation of G2 phase of mitotic cell cycle)) 37.63%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001220](http://purl.obolibrary.org/obo/GO_2001220) (obsolete negative regulation of G2 phase of mitotic cell cycle)) 37.63%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001219](http://purl.obolibrary.org/obo/GO_2001219) (obsolete positive regulation of S/G2 transition of mitotic cell cycle)) 37.63%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001218](http://purl.obolibrary.org/obo/GO_2001218) (obsolete negative regulation of S/G2 transition of mitotic cell cycle)) 37.63%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001217](http://purl.obolibrary.org/obo/GO_2001217) (obsolete regulation of S/G2 transition of mitotic cell cycle)) 37.63%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001052](http://purl.obolibrary.org/obo/GO_2001052) (null)) 37.63%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001048](http://purl.obolibrary.org/obo/GO_2001048) (null)) 37.63%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001047](http://purl.obolibrary.org/obo/GO_2001047) (null)) 37.63%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001041](http://purl.obolibrary.org/obo/GO_2001041) (null)) 37.63%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2000976](http://purl.obolibrary.org/obo/GO_2000976) (obsolete regulation of transcription from RNA polymerase II promoter involved in detection of glucose)) 37.63%


